Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular (IM) depot formulation for the maintenance treatment of adults with schizophrenia.

8 May 2012

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).

7 May 2012

Study captures positive experiences of people with bipolar disorder

The problems of living with bipolar have been well documented, but a new study by Lancaster University has captured the views of those who also report highly-valued, positive experiences of living with the condition.

4 May 2012

FDA issues Complete Response Letter to Alexza’s ADASUVE NDA

Alexza Pharmaceuticals, Inc. announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ADASUVE (loxapine) inhalation powder, 5 mg and 10 mg.

4 May 2012

Parental history of psychosis linked with increased risk of epilepsy in offspring

Although the two disorders may seem dissimilar, epilepsy and psychosis are associated. Individuals with epilepsy are more likely to have schizophrenia, and a family history of epilepsy is a risk factor for psychosis. It is not known whether the converse is true, i.e., whether a family history of psychosis is a risk factor for epilepsy.

3 May 2012

Only few clinical trials are being conducted to test drugs in pediatric patients

Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.

30 Apr 2012

U-M project to examine link between bipolar disorder and abnormalities in the circadian

A math professor at the University of Michigan will lead an international, $1 million project examining the links between bipolar disorder and abnormalities in the circadian, or daily, rhythms of a mammal's internal clock.

25 Apr 2012

Impaired mitochondrial function may play a major role in mood and psychotic disorders

Janssen Research & Development, LLC announced today the publication of an article that reviews the growing evidence that impaired mitochondrial function may play a major role in mood and psychotic disorders.

25 Apr 2012

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

SK Biopharmaceuticals, a South Korean pharmaceutical company, announced today that it was granted special status by the U.S. Food and Drug Administration (FDA) for carisbamate for the management of patients with infantile spasms (IS), a form of epilepsy associated with increased risk of death or mental retardation.

20 Apr 2012

Brain size and IQ secret may lie in genes: Study

The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.

18 Apr 2012

Northwestern's Stone Institute launches new program to combat mental illnesses at first signs

Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.

17 Apr 2012

New genes may explain individual differences in brain size and intelligence

In the world's largest brain study to date, a team of more than 200 scientists from 100 institutions worldwide collaborated to map the human genes that boost or sabotage the brain's resistance to a variety of mental illnesses and Alzheimer's disease.

16 Apr 2012

Emotional and instrumental support likely to play a critical role in recovery from mental illness

Does the growing number of psychiatric disorder diagnoses have an effect on people with mental illnesses? According to a new study, as definitions of mental illnesses become broader, people who show signs of depression and other common mental illnesses are less likely to evoke a supportive response from friends and family members as are people with other severe mental disorders.

10 Apr 2012

Research roundup: Effects of health exchanges; Improving provider performance; Governors' 2013 budgets and Medicaid

Authors analyzed the cost and coverage implications of various scenarios of the health insurance exchanges that are called for in the health law. They predicted that about 1 million uninsured people in the state would get insurance through the exchanges and said that premiums in the small group and individual market would be lower than if the health law was not in effect.

7 Apr 2012

Stem Cells reports results of Neuralstem ALS Phase I trial

Neuralstem, Inc. announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cells, on March 13th.

29 Mar 2012

Mylan receives FDA approval for generic Seroquel ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.

29 Mar 2012

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals, a South Korean pharmaceutical company, announced today that the first patient was dosed in a phase 2 clinical trial in the US for patients suffering with chronic constipation using their new chemical entity YKP10811.

17 Mar 2012

Smartphone technology can help assess and treat schizophrenia

Psychiatry is employing smartphone technology as an innovative tool in the assessment and treatment of schizophrenia and other serious mental illness. Prominent in this endeavor is Dror Ben-Zeev, an assistant professor of psychiatry at Dartmouth Medical School and director of the Thresholds-Dartmouth Research Center in Chicago.

16 Mar 2012

Scientists gain insight into why lithium salts are effective at treating bipolar disorder

Scientists have gained insight into why lithium salts are effective at treating bipolar disorder in what could lead to more targeted therapies with fewer side-effects.

14 Mar 2012

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.

12 Mar 2012

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Study captures positive experiences of people with bipolar disorder

FDA issues Complete Response Letter to Alexza’s ADASUVE NDA

Parental history of psychosis linked with increased risk of epilepsy in offspring

Only few clinical trials are being conducted to test drugs in pediatric patients

U-M project to examine link between bipolar disorder and abnormalities in the circadian

Impaired mitochondrial function may play a major role in mood and psychotic disorders

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

Brain size and IQ secret may lie in genes: Study

Northwestern's Stone Institute launches new program to combat mental illnesses at first signs

New genes may explain individual differences in brain size and intelligence

Emotional and instrumental support likely to play a critical role in recovery from mental illness

Research roundup: Effects of health exchanges; Improving provider performance; Governors' 2013 budgets and Medicaid

Stem Cells reports results of Neuralstem ALS Phase I trial

Mylan receives FDA approval for generic Seroquel ANDA

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

Smartphone technology can help assess and treat schizophrenia

Scientists gain insight into why lithium salts are effective at treating bipolar disorder

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in